Skip to main content
Top
Published in: BMC Pediatrics 1/2020

01-12-2020 | Ehlers-Danlos Syndrome | Case report

Classic Ehlers–Dalnos syndrome presenting as atypical chronic haematoma: a case report with novel frameshift mutation in COL5A1

Authors: Wei-Ching Chiu, Shu-Huey Chen, Mei-Chen Lo, Yung-Ting Kuo

Published in: BMC Pediatrics | Issue 1/2020

Login to get access

Abstract

Background

Ehlers–Danlos syndrome (EDS) is a group of inherited connective tissue disorders characterized by skin hyperextensibility, joint hypermobility and soft tissue vulnerable to blunt injury. Early recognition and diagnosis are crucial to patients to provide appropriate treatment, as well as to screen for life-threatening conditions such as aortic dissection and hollow organ perforation. The diagnosis of EDS is made based on clinical presentations, skin biopsy, and electron microscopy findings. To date, mutations in at least 20 genes have been found to cause the Ehlers-Danlos syndromes. However, EDS is still underestimated due to lack of awareness of its variable clinical presentations. Here we reported an EDS case with atypical initial presentation and a novel genetic mutation.

Case presentation

This 4-year-old Taiwanese male patient presented with easy bruising, multiple ecchymoses, joint hypermobility, hyperextensible skin, and prolonged pretibial haematoma. He was initially suspected of a bleeding tendency due to coagulation disorders. The coagulation test results were normal. DNA sequencing was performed for molecular diagnosis. Subsequently, the diagnosis of classical EDS was made by identifying a novel frameshift mutation in COL5A1 [NM_000093.4:c.4211_4212delAG, p.Gln1404Arg]. This mutation in the type V collagen gene COL5A1 contributes to the phenotype of classical EDS. This novel frameshift mutation may disturb the structural stability of collagen V and interfere with its heparin binding capacity, explaining the chronic haematoma.

Conclusion

The reported case showed the unusual features of chronic haematoma. This novel frameshift mutation and its phenotype correlation can provide useful information for practitioners about early recognition in Ehlers–Danlos syndrome.
Appendix
Available only for authorised users
Literature
1.
go back to reference Sobey G. Ehlers-Danlos syndrome: how to diagnose and when to perform genetic tests. Arch Dis Child. 2015;100(1):57–61.CrossRefPubMed Sobey G. Ehlers-Danlos syndrome: how to diagnose and when to perform genetic tests. Arch Dis Child. 2015;100(1):57–61.CrossRefPubMed
2.
go back to reference Mulvey MR, Macfarlane GJ, Beasley M, et al. Modest association of joint hypermobility with disabling and limiting musculoskeletal pain: results from a large-scale general population-based survey. Arthritis Care Res. 2013;65(8):1325–33.CrossRef Mulvey MR, Macfarlane GJ, Beasley M, et al. Modest association of joint hypermobility with disabling and limiting musculoskeletal pain: results from a large-scale general population-based survey. Arthritis Care Res. 2013;65(8):1325–33.CrossRef
4.
go back to reference Malfait F, Francomano C, Byers P, Belmont J, Berglund B, Black J, et al. The 2017 international classification of the Ehlers-Danlos syndromes. Am J Med Genet C Semin Med Genet. 2017;175(1):8–26.CrossRefPubMed Malfait F, Francomano C, Byers P, Belmont J, Berglund B, Black J, et al. The 2017 international classification of the Ehlers-Danlos syndromes. Am J Med Genet C Semin Med Genet. 2017;175(1):8–26.CrossRefPubMed
5.
go back to reference Bowen JM, Sobey GJ, Burrows NP, Colombi M, Lavallee ME, Malfait F, Francomano CA. Ehlers-Danlos syndrome, classical type. Am J Med Genet C Semin Med Genet. 2017;175(1):27–39.CrossRefPubMed Bowen JM, Sobey GJ, Burrows NP, Colombi M, Lavallee ME, Malfait F, Francomano CA. Ehlers-Danlos syndrome, classical type. Am J Med Genet C Semin Med Genet. 2017;175(1):27–39.CrossRefPubMed
6.
go back to reference Watanabe M, Nakagawa R, Naruto T, Kohmoto T, Suga K, Goji A, et al. A novel missense mutation of COL5A2 in a patient with Ehlers-Danlos syndrome. Hum Genome Var. 2016;15(3):16030.CrossRef Watanabe M, Nakagawa R, Naruto T, Kohmoto T, Suga K, Goji A, et al. A novel missense mutation of COL5A2 in a patient with Ehlers-Danlos syndrome. Hum Genome Var. 2016;15(3):16030.CrossRef
7.
go back to reference Beighton P, Horan F. Orthopaedic aspects of the Ehlers-Danlos syndrome. J Bone Joint Surg Br. 1969;51(3):444–53.CrossRefPubMed Beighton P, Horan F. Orthopaedic aspects of the Ehlers-Danlos syndrome. J Bone Joint Surg Br. 1969;51(3):444–53.CrossRefPubMed
8.
go back to reference de Almeida HL Jr, Bicca E, Rocha NM, de Castro LA. Light and electron microscopy of classical Ehlers-Danlos syndrome. Am J Dermatopathol. 2013;35(1):102–5.CrossRefPubMed de Almeida HL Jr, Bicca E, Rocha NM, de Castro LA. Light and electron microscopy of classical Ehlers-Danlos syndrome. Am J Dermatopathol. 2013;35(1):102–5.CrossRefPubMed
11.
go back to reference De Paepe A, Malfait F. Bleeding and bruising in patients with Ehlers-Danlos syndrome and other collagen vascular disorders. Br J Haematol. 2004;127(5):491–500.CrossRefPubMed De Paepe A, Malfait F. Bleeding and bruising in patients with Ehlers-Danlos syndrome and other collagen vascular disorders. Br J Haematol. 2004;127(5):491–500.CrossRefPubMed
12.
go back to reference Birk DE. Type V collagen: heterotypic type I/V collagen interactions in the regulation of fibril assembly. Micron. 2001;32(3):223–37.CrossRefPubMed Birk DE. Type V collagen: heterotypic type I/V collagen interactions in the regulation of fibril assembly. Micron. 2001;32(3):223–37.CrossRefPubMed
13.
go back to reference Takahara K, Hoffman GG, Greenspan DS. Complete structural organization of the human alpha 1 (V) collagen gene (COL5A1): divergence from the conserved organization of other characterized fibrillar collagen genes. Genomics. 1995;29(3):588–97.CrossRefPubMed Takahara K, Hoffman GG, Greenspan DS. Complete structural organization of the human alpha 1 (V) collagen gene (COL5A1): divergence from the conserved organization of other characterized fibrillar collagen genes. Genomics. 1995;29(3):588–97.CrossRefPubMed
14.
go back to reference Ritelli M, Dordoni C, Venturini M, Chiarelli N, Quinzani S, Traversa M, et al. Clinical and molecular characterization of 40 patients with classic Ehlers-Danlos syndrome: identification of 18 COL5A1 and 2 COL5A2 novel mutations. Orphanet J Rare Dis. 2013;8:58.CrossRefPubMedPubMedCentral Ritelli M, Dordoni C, Venturini M, Chiarelli N, Quinzani S, Traversa M, et al. Clinical and molecular characterization of 40 patients with classic Ehlers-Danlos syndrome: identification of 18 COL5A1 and 2 COL5A2 novel mutations. Orphanet J Rare Dis. 2013;8:58.CrossRefPubMedPubMedCentral
15.
go back to reference Mitchell AL, Schwarze U, Jennings JF, Byers PH. Molecular mechanisms of classical Ehlers-Danlos syndrome (EDS). Hum Mutat. 2009;30(6):995–1002.CrossRefPubMed Mitchell AL, Schwarze U, Jennings JF, Byers PH. Molecular mechanisms of classical Ehlers-Danlos syndrome (EDS). Hum Mutat. 2009;30(6):995–1002.CrossRefPubMed
16.
go back to reference Malfait F, Coucke P, Symoens S, Loeys B, Nuytinck L, De Paepe A. The molecular basis of classic Ehlers-Danlos syndrome: a comprehensive study of biochemical and molecular findings in 48 unrelated patients. Hum Mutat. 2005;25(1):28–37.CrossRefPubMed Malfait F, Coucke P, Symoens S, Loeys B, Nuytinck L, De Paepe A. The molecular basis of classic Ehlers-Danlos syndrome: a comprehensive study of biochemical and molecular findings in 48 unrelated patients. Hum Mutat. 2005;25(1):28–37.CrossRefPubMed
17.
18.
go back to reference Symoens S, Malfait F, Renard M, André J, Hausser I, Loeys B, Coucke P, De Paepe A. COL5A1 signal peptide mutations interfere with protein secretion and cause classic Ehlers-Danlos syndrome. Hum Mutat. 2009;30(2):E395–403.CrossRefPubMed Symoens S, Malfait F, Renard M, André J, Hausser I, Loeys B, Coucke P, De Paepe A. COL5A1 signal peptide mutations interfere with protein secretion and cause classic Ehlers-Danlos syndrome. Hum Mutat. 2009;30(2):E395–403.CrossRefPubMed
19.
go back to reference Delacoux F, Fichard A, Geourjon C, Garrone R, Ruggiero F. Molecular features of the collagen V heparin binding site. J Biol Chem. 1998;273(24):15069–76.CrossRefPubMed Delacoux F, Fichard A, Geourjon C, Garrone R, Ruggiero F. Molecular features of the collagen V heparin binding site. J Biol Chem. 1998;273(24):15069–76.CrossRefPubMed
20.
go back to reference Yaoi Y, Hashimoto K, Koitabashi H, Takahara K, Ito M, Kato I. Primary structure of the heparin-binding site of type V collagen. Biochim Biophys Acta. 1990;1035(2):139–45.CrossRefPubMed Yaoi Y, Hashimoto K, Koitabashi H, Takahara K, Ito M, Kato I. Primary structure of the heparin-binding site of type V collagen. Biochim Biophys Acta. 1990;1035(2):139–45.CrossRefPubMed
21.
go back to reference Ricard-Blum S, Beraud M, Raynal N, Farndale RW, Ruggiero F. Structural requirements for heparin/heparan sulfate binding to type V collagen. J Biol Chem. 2006;281(35):25195–204.CrossRefPubMed Ricard-Blum S, Beraud M, Raynal N, Farndale RW, Ruggiero F. Structural requirements for heparin/heparan sulfate binding to type V collagen. J Biol Chem. 2006;281(35):25195–204.CrossRefPubMed
22.
go back to reference Delacoux F, Fichard A, Cogne S, Garrone R, Ruggiero F. Unraveling the amino acid sequence crucial for heparin binding to collagen V. J Biol Chem. 2000;275(38):29377–82.CrossRefPubMed Delacoux F, Fichard A, Cogne S, Garrone R, Ruggiero F. Unraveling the amino acid sequence crucial for heparin binding to collagen V. J Biol Chem. 2000;275(38):29377–82.CrossRefPubMed
23.
go back to reference Persikov AV, Pillitteri RJ, Amin P, Schwarze U, Byers PH, Brodsky B. Stability related bias in residues replacing glycines within the collagen triple helix (Gly-Xaa-Yaa) in inherited connective tissue disorders. Hum Mutat. 2004;24(4):330–7.CrossRefPubMed Persikov AV, Pillitteri RJ, Amin P, Schwarze U, Byers PH, Brodsky B. Stability related bias in residues replacing glycines within the collagen triple helix (Gly-Xaa-Yaa) in inherited connective tissue disorders. Hum Mutat. 2004;24(4):330–7.CrossRefPubMed
Metadata
Title
Classic Ehlers–Dalnos syndrome presenting as atypical chronic haematoma: a case report with novel frameshift mutation in COL5A1
Authors
Wei-Ching Chiu
Shu-Huey Chen
Mei-Chen Lo
Yung-Ting Kuo
Publication date
01-12-2020
Publisher
BioMed Central
Published in
BMC Pediatrics / Issue 1/2020
Electronic ISSN: 1471-2431
DOI
https://doi.org/10.1186/s12887-020-02386-1

Other articles of this Issue 1/2020

BMC Pediatrics 1/2020 Go to the issue